Amanda Barbeau, MPH, is a Program Associate of the Clinical Effectiveness and Decision Science Program at the Patient-Centered Outcomes Research Institute (PCORI). In this role, she is responsible for coordinating and managing projects related to Comparative Effectiveness Research (CER) Methods.

Barbeau has experience in research conduct and implementation, having coordinated clinical and community-based research at Boston University Medical Center, Boston University, Massachusetts General Hospital, and the University of Washington, and healthcare delivery working as an applied behavior analysis therapist for individuals with autism spectrum disorder. She has authored a manuscript on the perceived efficacy of nicotine replacement therapy among e-cigarette users. Barbeau previously was involved in health policy and advocacy, having completed an internship with the American Medical Student Association. She also has worked on healthcare legislation at the state and national levels, and served on the AMSA Board of Trustees during her final year with the organization.

Barbeau earned a BS in neurobiology, physiology and behavior, and a BA in neuroscience from the University of California, Davis, and an MPH in community health and socio-behavioral sciences at Boston University.